Perbedaan Kentanix Supra International Tbk. dan Organon Pharma Indonesia Tbk.: Kentanix Supra International Tbk. diperdagangkan di Rp406 (kapitalisasi pasar 867,96 M, volume 24 jam 81,6 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Kentanix Supra International Tbk. jauh lebih besar — sekitar 8,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| KSIX | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 867,96 M | 104,4 M |
Volume | 81,6 rb | — |
Lot | 816 | — |
Perputaran | 33,19 jt | — |
Harga Rata-rata | 406,78 | — |
Nilai Transaksi | 33,19 jt | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Kentanix Supra International Tbk (the Company) was established based on Notarial Deed No. 41 dated October 27, 1980 of Samsul Hadi, S.H., as amended by Deed No. 25 dated April 8, 1981 and Deed No. 10 dated October 9, 1981 of the same Notary. The Company commenced its commercial operations in 1985. PT Badra Arta, a company incorporated in Indonesia, is the parent entity of the Company.
Selengkapnya di halaman KSIX →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →